Rezolute, Inc.
USD5.20
+0.10 (+1.96%)
CEO
Nevan Charles Elam
IPO Date
2013-01-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.12
Prev. Close
$5.10
Day Low
$4.98
Day High
$5.31
52W Low
$1.07
52W High
$11.46
Market Cap
$0.50B
Volume
3.36M
| -3.2 |
| 30 Jun 2023 | FY | 0.0% | 0.0% | -44.6% | -41.9% | 0.02 | 20.18 | -2.0 |
| 30 Jun 2022 | FY | 0.0% | 0.0% | -27.5% | -26.9% | 0.00 | 61.78 | -1.4 |
| 30 Jun 2021 | FY | 0.0% | 0.0% | -80.1% | -49.1% | 0.55 | 21.34 | -5.2 |
| 30 Jun 2020 | FY | 0.0% | 0.0% | -276.1% | -185.4% | 0.06 | 3.26 | -1.3 |
| 30 Jun 2019 | FY | 0.0% | 0.0% | -1736.1% | -248.3% | 0.01 | 1.45 | -0.6 |
| 30 Jun 2018 | FY | 0.0% | 0.0% | 753.9% | -1193.1% | -0.87 | 0.32 | -0.8 |
| 30 Jun 2017 | FY | 0.0% | 0.0% | -237.8% | -190.8% | 0.00 | 2.78 | -2.3 |
| 30 Jun 2016 | FY | 0.0% | 0.0% | -170.2% | -137.0% | 0.01 | 2.60 | -1.7 |
| -2.7 |
| 30 Sept 2025 | Q1 | 0.0% | 0.0% | -12.3% | -11.4% | 0.01 | 15.15 | -13.4 |
| 30 Jun 2025 | Q4 | 0.0% | 0.0% | -15.0% | -13.9% | 0.01 | 14.37 | -4.3 |
| 31 Mar 2025 | Q3 | 0.0% | 0.0% | -22.9% | -20.0% | 0.02 | 8.43 | -2.7 |
| 31 Dec 2024 | Q2 | 0.0% | 0.0% | -15.8% | -14.0% | 0.02 | 9.30 | -5.4 |
| 30 Sept 2024 | Q1 | 0.0% | 0.0% | -13.6% | -12.5% | 0.02 | 13.79 | -5.5 |
| 30 Jun 2024 | Q4 | 0.0% | 0.0% | -19.0% | -17.3% | 0.02 | 13.39 | -2.4 |
| 31 Mar 2024 | Q3 | 0.0% | 0.0% | -24.1% | -19.4% | 0.03 | 11.82 | -1.8 |
| 31 Dec 2023 | Q2 | 0.0% | 0.0% | -15.2% | -13.6% | 0.03 | 12.00 | -0.9 |